Frances is a Partner at the Joint Operation firm Kewei in Shanghai. She advises on competition law issues across a broad range of industries, including pharmaceuticals, TMT, automotive, luxury products, energy, essential facilities and public utilities.
17
On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined 3 pharmaceutical companies for abuse of dominance in the distribution of injectable calcium gluconate Active Pharmaceutical Ingredient (API). The three companies were found to be in breach of the PRC’s Anti-Monopoly (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
61-63 Rochester Place
NW1 9JU London, UK
